View drug registration information details.
Items | Registration information |
ID | 669 |
No | 669 |
Brand Name | GABLIN CAPSULE 75 MG |
Ingredients | PREGABALIN 75 MG |
Dosage Form | CAPSULE |
Primary Packaging | ALU-ALU |
Storage | STORE BELOW 30C |
Shelf Life | 3 YEARS |
Pack Size | 2 X 7'S/BOX |
Dispensing Category | Prescription only |
ATC Classification | XX |
Pharmaceutical Class | ANTIEPILEPTIC |
Indications | NEUROPATHIC PAIN, EPILEPSY, GENERALIZED ANXIETY DISORDER |
Contraindications | HYPERSENSITIVITY |
Side Effects | TIREDNESS, DIZZINESS, HEADACHE, SOMNOLENCE, PERIPHERAL EDEMA, DRY MOUTH, NAUSEA, VOMITING, CONSTIPATION, BLURRED VISION, DOUBLE VISION, HIVES, RASH, ITCHING, SWELLING OF THE EYES, FACE, THROAT, MOUTH, LIPS, TONGUE, HEAD OR NECK |
Unit Price | 0.90$ |
EDL |
Yes |
Description | BLUE COLORED SIZE NO 2 PROPERLY LOCKED CAPSULE CONTAINING WHITE TO ALMOST WHITE CRYSTALLINE POWDER |
Note | |
License Owner | EXAMED CO.,LTD |
Manufacturer | CCL PHARMACEUTICALS (PVT.) LTD. |
Country | PAKISTAN |
Import Registration No | 50257 |
Import Registration Date | 2008-07-26 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2021-06-17 |
FDD Registration No | 04 I 4382/18 |
FDD Registration Date | 2022-05-13 |
Expiry Date | 2025-05-12 |
Back to drug list
|